JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

84 hedge funds and large institutions have $81.8M invested in Jounce Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$18K
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$4.04M
2 -$2.44M
3 -$1.42M
4
Man Group
Man Group
United Kingdom
-$1.3M
5
BlackRock
BlackRock
New York
-$1.3M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$34.5M
2
$10.3M
3
$5.09M
4
$3.59M
5
$3.39M
6
$2.09M
7
$1.79M
8
$1.61M
9
$1.54M
10
$1.35M
11
$1.04M
12
$1M
13
$943K
14
$901K
15
$864K
16
$812K
17
$735K
18
$714K
19
$619K
20
$567K
21
$543K
22
$506K
23
$471K
24
$445K
25
$443K